Ascend Laboratories LLC is recalling approximately 11,352 bottles of Atorvastatin Calcium Tablets (80 mg), a cholesterol-lowering medication, including both 90-count and 500-count bottles. The recall was initiated because the tablets failed dissolution specifications, meaning the medication may not dissolve properly in the body as intended. This could potentially reduce the drug's effectiveness in managing cholesterol levels. These prescription medications were manufactured by Alkem Laboratories in India and distributed to wholesalers throughout the United States.
If the medication fails to dissolve correctly, the active ingredient may not be absorbed into the bloodstream at the required rate, which could lead to poorly controlled cholesterol levels and a potential increase in cardiovascular risk over time.
Pharmaceutical guidance and refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.